This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by van der Voet, G.B. Articles by de Wolff, F.A. Search for Related Content PubMed Articles by van der Voet, G.B. Articles by de Wolff, F.A. Social Bookmarking                   What's this?

Distribution of Aluminium between Plasma and Erythrocytes

Toxicology Laboratory, University Hospital, POB 9600, 2300 RC Leiden, The Netherlands

F.A. de Wolff

Toxicology Laboratory, University Hospital, POB 9600, 2300 RC Leiden, The Netherlands

1 It is common use to monitor body burdens of toxic trace metals by measuring concentrations in whole blood. To monitor aluminium (Al) body burden in renal patients on haemodialysis, which is a high-risk group for Al poisoning, the concentrations of Al in plasma (AIP) or serum (AlS) are determined rather than Al in whole blood (AlB).

2 To evaluate this custom, which exists in clinical laboratories, an investigation was made into the distribution of Al between the plasma and the blood-cell compartment and on the extent of binding of Al to the blood cells both in rats and in dialysed patients.

3 The results show that Al is distributed between plasma and blood cells with only very small quantitative differences, that binding of Al to blood cells is very weak and that AlP and AIB have similar prognostic value for toxicity.

Human & Experimental Toxicology, Vol. 4, No. 6, 643-648 (1985)
DOI: 10.1177/096032718500400613


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?